Where are we moving in the classification of idiopathic infl... : Current Opinion in Neurology
Where are we moving in the classification of idiopathic inflammatory myopathies? : Current …

Inclusion body myositis (IBM) is a progressive muscle disease affecting patients over the
age of 40, with distinctive clinical and histopathological features. The typical clinical …

Classification of idiopathic inflammatory myopathies: pathol... : Current Opinion in
Neurology Classification of idiopathic inflammatory myopathies: pathology perspectives …

Addressing the obstacles encountered by patients with IBM and the medical community
presents a multitude of challenges. Effectively surmounting these hurdles requires …

In recent years, an autoantibody directed against the 5′-citosolic nucleotidase1A (cN1A)
was identified in the sera of sporadic inclusion body myositis (s-IBM) patients with widely …

Objective We performed a population‐based study on inclusion body myositis with the
primary aims to define the prevalence, survival rate, and incidence, and to investigate the …

Inclusion body myositis (IBM) is an acquired idiopathic inflammatory myopathy more
commonly seen in individuals aged above 50. Unlike other idiopathic inflammatory …

Inflammatory neuromuscular disorders encompass a diverse group of immune-mediated
diseases with varying clinical manifestations and treatment responses. The identification of …

Introduction Inclusion body myositis (IBM) is a progressive inflammatory myopathy
characterised by skeletal muscle infiltration and myofibre invasion by CD8+ T lymphocytes …

Objective To describe systemic sclerosis (SSc) with myopathy in patients without classic SSc-
specific and SSc-overlap autoantibodies (aAbs), referred to as seronegative scleromyositis …